DiaSorin, MeMed Ink Italian Distribution Deal for Test to Differentiate Bacterial, Viral Infection
The partnership enables DiaSorin to distribute the MeMed BV test on the Liaison XL and XS as well as on the MeMed Key point-of-need system.
Meridian Bioscience Nabs FDA Clearance for Shiga Toxin Assay
The immunoassay expands Meridian's gastrointestinal product line with a test that can help identify infections with Shiga toxin-producing Escherichia coli.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.
Cepheid Nabs CE Mark for Group B Strep Test
The PCR-based Xpert Xpress GBS test can help screen pregnant women for Streptococcus infections that can lead to early-onset neonatal sepsis.
Molecular TB Assay From PBD Biotech Shows Promise in Detecting Latent-to-Active Disease Risk
The blood-based assay, called Actiphage, combines phage-induced lysis of infectious bacteria and molecular detection of bacterial DNA.